A UHPLC–MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption

IF 2.1 Q4 Chemistry Clinical Mass Spectrometry Pub Date : 2017-01-01 DOI:10.1016/j.clinms.2017.02.001
Jean-Christophe Prost , Felix Brunner , Cédric Bovet , Christian Grob , Christian Berchtold , Götz Schlotterbeck , Dino Kröll , Carlo R. Largiadèr , Georg Martin Fiedler , Pascal Juillerat
{"title":"A UHPLC–MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption","authors":"Jean-Christophe Prost ,&nbsp;Felix Brunner ,&nbsp;Cédric Bovet ,&nbsp;Christian Grob ,&nbsp;Christian Berchtold ,&nbsp;Götz Schlotterbeck ,&nbsp;Dino Kröll ,&nbsp;Carlo R. Largiadèr ,&nbsp;Georg Martin Fiedler ,&nbsp;Pascal Juillerat","doi":"10.1016/j.clinms.2017.02.001","DOIUrl":null,"url":null,"abstract":"<div><p>Bile acids malabsorption (BAM) is encountered in numerous gastrointestinal pathologies and is a good example of a treatable cause of watery diarrhea after ileal resection. The gold standard for diagnosing BAM is the selenium homocholic acid taurine test (SeHCAT), an expensive and complex analysis. An alternative method is the quantification of 7α-hydroxy-4-cholesten-3-one (C4). Here, we present a simple, ultra high-performance liquid chromatography–tandem mass spectrometry method to measure C4 in human serum. To avoid time consuming sample preparation (e.g., derivatization, solid phase extraction), we used absorption chemistry-based extraction plates. This method demonstrates a lower limit of quantification of 5<!--> <!-->ng/mL and is linear over a concentration range from 5 to 300<!--> <!-->ng/mL (R<sup>2</sup> <!-->=<!--> <!-->0.9977). Inaccuracy and imprecision were less than 15%. The validated method is currently used for routine measurement of C4 from serum in patients to confirm BAM diagnosis.</p></div>","PeriodicalId":48565,"journal":{"name":"Clinical Mass Spectrometry","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.clinms.2017.02.001","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Mass Spectrometry","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2376999816300241","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Chemistry","Score":null,"Total":0}
引用次数: 1

Abstract

Bile acids malabsorption (BAM) is encountered in numerous gastrointestinal pathologies and is a good example of a treatable cause of watery diarrhea after ileal resection. The gold standard for diagnosing BAM is the selenium homocholic acid taurine test (SeHCAT), an expensive and complex analysis. An alternative method is the quantification of 7α-hydroxy-4-cholesten-3-one (C4). Here, we present a simple, ultra high-performance liquid chromatography–tandem mass spectrometry method to measure C4 in human serum. To avoid time consuming sample preparation (e.g., derivatization, solid phase extraction), we used absorption chemistry-based extraction plates. This method demonstrates a lower limit of quantification of 5 ng/mL and is linear over a concentration range from 5 to 300 ng/mL (R2 = 0.9977). Inaccuracy and imprecision were less than 15%. The validated method is currently used for routine measurement of C4 from serum in patients to confirm BAM diagnosis.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
7α-羟基-4-胆甾醇-3-酮的UHPLC-MS /MS定量方法在胆汁酸吸收不良诊断中的应用
胆汁酸吸收不良(BAM)在许多胃肠道疾病中遇到,是回肠切除术后水样腹泻的可治疗原因的一个很好的例子。诊断BAM的金标准是硒同胆酸牛磺酸试验(SeHCAT),这是一种昂贵且复杂的分析方法。另一种方法是定量测定7α-羟基-4-胆甾-3-酮(C4)。在这里,我们提出了一种简单的,超高效液相色谱-串联质谱法测定人血清中的C4。为了避免耗时的样品制备(例如衍生化,固相萃取),我们使用了基于吸收化学的萃取板。该方法的定量下限为5 ng/mL,在5 ~ 300 ng/mL的浓度范围内呈线性(R2 = 0.9977)。不准确和不精确小于15%。该验证方法目前用于常规测量患者血清C4以确认BAM诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Mass Spectrometry
Clinical Mass Spectrometry Chemistry-Spectroscopy
CiteScore
1.70
自引率
0.00%
发文量
0
期刊介绍: Clinical Mass Spectrometry publishes peer-reviewed articles addressing the application of mass spectrometric technologies in Laboratory Medicine and Clinical Pathology with the focus on diagnostic applications. It is the first journal dedicated specifically to the application of mass spectrometry and related techniques in the context of diagnostic procedures in medicine. The journal has an interdisciplinary approach aiming to link clinical, biochemical and technological issues and results.
期刊最新文献
Mass spectrometry in clinical glycomics: The path from biomarker identification to clinical implementation A proposal for score assignment to characterize biological processes from mass spectral analysis of serum Analysis of urinary VOCs using mass spectrometric methods to diagnose cancer: A review Analysis of 17 fentanyls in plasma and blood by UPLC-MS/MS with interpretation of findings in surgical and postmortem casework Collision energy-breakdown curves – An additional tool to characterize MS/MS methods
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1